Zobrazeno 1 - 10
of 1 317
pro vyhledávání: '"Won Sohn"'
Autor:
Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 274-285 (2024)
Backgrounds/Aims The treatment landscape for hepatocellular carcinoma (HCC) has significantly evolved over the past decade. We aimed to analyze trends in treatment patterns for HCC using a nationwide claims database from the Korean Health Insurance R
Externí odkaz:
https://doaj.org/article/fdf016e98ba94399b77b85c118706a01
Autor:
Jong-In Chang, Jung Hee Kim, Dong Hyun Sinn, Ju-Yeon Cho, Kwang Min Kim, Joo Hyun Oh, Yewan Park, Won Sohn, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung-Woon Paik
Publikováno v:
Gut and Liver, Vol 17, Iss 4, Pp 620-628 (2023)
Background/Aims: The ursodeoxycholic acid (UDCA) response score (URS) was developed to identify poor responders to UDCA before treatment, in order to offer timely and proactive intervention. However, validation of the URS in Asian population is warra
Externí odkaz:
https://doaj.org/article/40a8ec8bb19e454aa028285d41e27305
Autor:
Kwang Gyun Lee, Seung-Joo Nam, Hyuk Soon Choi, Hang Lak Lee, Jai Hoon Yoon, Chan Hyuk Park, Kyoung Oh Kim, Do Hoon Kim, Jung-Wook Kim, Won Sohn, Sung Hoon Jung
Publikováno v:
Clinical Endoscopy, Vol 56, Iss 3, Pp 333-339 (2023)
Background/Aims Intragastric balloon (IGB) is the only available endoscopic bariatric and metabolic therapy in Korea. End-ball (Endalis) has the longest history of clinical use among the IGBs available in Korea. However, little clinical data on this
Externí odkaz:
https://doaj.org/article/8c8be1951c254c95aa4052baad84d5bf
Autor:
Ju-Yeon Cho, Won Sohn
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 2, Pp 374-376 (2023)
Externí odkaz:
https://doaj.org/article/b36c5d35a1f1485094d5858f43406885
Autor:
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun‐Suk Jung, Chan‐won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne
Publikováno v:
Hepatology Communications, Vol 6, Iss 9, Pp 2238-2252 (2022)
Abstract The effect of sarcopenic visceral obesity on the risk of nonalcoholic fatty liver disease (NAFLD) is uncertain. We investigated (a) whether the skeletal muscle mass to visceral fat area ratio (SV ratio), as a measure of sarcopenic visceral o
Externí odkaz:
https://doaj.org/article/cf55e137396449e7b468155aaff77ed7
Autor:
Won Sohn, Yong-Han Paik
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 1, Pp 182-184 (2023)
Externí odkaz:
https://doaj.org/article/20e5163e8e0a495ba8b174ab6dfe2ead
Publikováno v:
Journal of Liver Cancer, Vol 22, Iss 1, Pp 51-56 (2022)
The concept of oligometastasis is widely accepted for various types of solid tumors; accordingly, better outcomes can be anticipated with aggressive local interventions. The treatment of advanced hepatocellular carcinoma (HCC) with extrahepatic metas
Externí odkaz:
https://doaj.org/article/7eee0b367f014ae1aa6d128040f2fa32
Autor:
Ju-Yeon Cho, Won Sohn
Publikováno v:
Gut and Liver, Vol 17, Iss 4, Pp 487-488 (2023)
Background/Aims: Many Japanese institutions use electromagnetic extracorporeal shock wave lithotripsy (ESWL) systems for treating pancreatic duct stones. However, there are no reports on direct comparisons between recent electromagnetic lithotripters
Externí odkaz:
https://doaj.org/article/d92093da075a4578889f5f28391b0058
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss Suppl, Pp S261-S267 (2023)
Non-alcoholic fatty liver disease (NAFLD) is accepted as a counterpart to alcohol-related liver disease because it is defined as hepatic steatosis without excessive use of alcohol. However, the definition of moderate alcohol consumption, as well as w
Externí odkaz:
https://doaj.org/article/2b9c4938d1514617994f114a6039af23
Publikováno v:
Gut Pathogens, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background Hepatitis B virus (HBV) infection is associated with a reduced risk of developing dyslipidemia and non-alcoholic fatty liver diseases. Given that the gut microbiota plays a significant role in cholesterol metabolism, we compared t
Externí odkaz:
https://doaj.org/article/1446b10f8cf14612938b7d595364a8a1